Abstract
The article describes a clinical case of asthmatic status in a child with severe bronchial asthma, which clearly demonstrates the importance of organizing rational medical care for this group of patients at the stage of a territorial polyclinic, where timely measures should be taken to assess the effectiveness of current anti-inflammatory therapy, review its scope, and especially paperwork to provide patients with vital medicines in the preferential drug treatment system provision of citizens. Personalized phenotype determination and therapy selection are needed for patients who do not achieve control on medium and high doses of inhaled glucocorticosteroids in combination with long-acting β2-agonists and who have a history of severe exacerbations. It is important to observe the continuity of medical care for such patients at the inpatient and outpatient stages.

This publication has 10 references indexed in Scilit: